HCG Aastha Cancer Centre Ahmedabad successfully hosted the 9th edition of the Oncosurgery Mastercourse (OM 9.0), a masterclass dedicated to the specialised field of salivary gland tumours. Given the surgical demands of salivary gland tumours, which require pinnacle surgical skills, OM 9.0 aimed to fine-tune the surgical abilities of participants through interactions with master surgeons who shared their experiences via curated master videos, didactic lectures and panel discussions.
The Oncosurgery Mastercourse has evolved into a significant educational event for the surgical community, offering participants a unique opportunity to interact with field experts and learn from their extensive experiences. This time, led ably by the organising chairman Dr Dushyant Mandlik and the team of senior head and neck cancer surgeons at HCG Aastha Cancer Centre, Ahmedabad— Dr Aditya Joshipura (Organising Secretary, OM 9.0), Dr Purvi Patel, Dr Parin Patel, and Dr Nitin Sharma..
A few notable topics covered during the master course included the retrograde approach for parotidectomy, modern approaches to facial reanimation and reconstructing facial arches after injury to the facial nerve, and the use of intraoperative neuromonitoring systems for better results in complicated scenarios.
The masterclass was attended by 125 healthcare professionals, including Dr Anil D’Cruz, Former UICC Chief, Dr Jyoti Dabholkar, Chairman, Governing Council of the Federation of Head Neck Oncology, and Dr Arvind Krishnamurthy, Professor of Surgical Oncology, Adyar, Chennai, along with 25 distinguished national faculty members. The event also featured a guest online lecture by Professor Joseph Dayan, a leading surgeon from MSKCC Hospital, New York
Dr Kaustubh Patel, Course Director, OM 9.0 and Director, HCG Aastha Cancer Centre, stated that It requires thorough knowledge and continuous upgradation of skills to handle complex cases in this area.
Adding to that, Dr Daxesh Patel, Course Director for OM 9.0 and Senior Consultant – Head and Neck Surgical Oncology, HCG Aastha Cancer Centre, said that continuous collaborative efforts and multi-modality treatments are the need of the hour. The diversity of perspectives and innovative approaches shared during the event has been a step in the right direction.